Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion of the historical financial conditions and results of operations in conjunction with our consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements which are subject to risks and uncertainties that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”
The following Management’s Discussion and Analysis (“MD&A”) relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this Quarterly Report on Form 10-Q. The MD&A is intended to enable the reader to understand the Company’s financial condition and results of operations, including any material changes in the Company’s financial condition and results of operations since December 31, 2023, and as compared with the three and six months ended June 30, 2024. The MD&A is provided as a supplement to and should be read in conjunction with the unaudited consolidated financial statements and notes thereto included in this Quarterly report on Form 10-Q, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Annual Report”).
In this MD&A, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.
Overview
Turning Point Brands, Inc. is a leading manufacturer, marketer and distributor of branded consumer products. We sell a wide range of products to adult consumers consisting of staple products with our iconic brands Zig-Zag® and Stoker’s® and our next generation products to fulfill evolving consumer preferences. Among other markets, we compete in the alternative smoking accessories and Other Tobacco Products (“OTP”) industries. The alternative smoking accessories market is a dynamic market experiencing robust secular growth driven by cannabinoid legalization in the U.S. and Canada, and positively evolving consumer perception and acceptance in North America. The OTP industry, which consists of non-cigarette tobacco products, exhibited low-single-digit consumer unit annualized growth over the four-year period ended 2023 as reported by Management Science Associates, Inc. a third-party analytics and information company. Our segments are led by our core proprietary and iconic brands: Zig-Zag® and CLIPPER® in the Zig-Zag Products segment and Stoker’s® along with Beech-Nut® and Trophy® in the Stoker’s Products segment. Our businesses generate solid cash flow which we use to invest in our business, finance acquisitions, increase brand support, expand our distribution infrastructure, and strengthen our capital position. We currently ship to approximately 820 distributors with an additional 650 secondary, indirect wholesalers in the U.S. that carry and sell our products. Under the leadership of a senior management team with extensive experience in the consumer products, alternative smoking accessories and tobacco industries, we have grown and diversified our business through new product launches, category expansions, and acquisitions while concurrently improving operational efficiency.
We believe there are meaningful opportunities to grow through investing in organic growth, acquisitions and joint ventures across all product categories. Our products are currently available in approximately 197,000 U.S. retail locations which, with the addition of retail stores in Canada, brings our total North American retail presence to an estimated 217,000 points of distribution. Our sales team targets widespread distribution to all traditional retail channels, including convenience stores, and we have a growing e-commerce business.
Products
We operate in three segments: Zig-Zag Products, Stoker’s Products and Creative Distribution Solutions (“CDS”). In our Zig-Zag Products segment, we principally market and distribute (i) rolling papers, tubes, and related products; (ii) finished cigars and make-your-own (“MYO”) cigar wraps; and (iii) CLIPPER reusable lighters and other accessories. In addition, we have a majority stake in Turning Point Brands Canada which is a specialty marketing and distribution firm focused on building brands in the Canadian cannabis accessories, tobacco and alternative products categories. In our Stoker’s Products segment, we (i) manufacture and market moist snuff tobacco (“MST”) and (ii) contract for and market loose leaf chewing tobacco products. In our Creative Distribution Solutions segment, we (i) market and distribute liquid nicotine products and certain other products without tobacco and/or nicotine; (ii) distribute a wide assortment of products to non-traditional retail via VaporBeast; and (iii) market and distribute a wide assortment of products to individual consumers via the VaporFi B2C online platform.
Operations
Our core Zig-Zag Products and Stoker’s Products segments primarily generate revenues from the sale of our products to wholesale distributors who, in turn, resell the products to retail operations. Our acquisition of Vapor Beast in 2016 expanded our revenue streams as we began selling directly to non-traditional retail outlets. Our acquisition of IVG in 2018 enhanced our B2C revenue stream with the addition of the Vapor-Fi online platform. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.
We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. Approximately 75% of our production, as measured by net sales, is outsourced to suppliers. The remaining production consists primarily of our moist snuff tobacco operations located in Dresden, Tennessee and Louisville, Kentucky. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel.
Key Factors Affecting Our Results of Operations
We consider the following to be the key factors affecting our results of operations:
| ● | Our ability to further penetrate markets with our existing products; |
| ● | Our ability to introduce new products and product lines that complement our core business; |
| ● | Decreasing interest in some tobacco products among consumers; |
| ● | Price sensitivity in our end-markets; |
| ● | Marketing and promotional initiatives, which cause variability in our results; |
| ● | Costs and increasing regulation of promotional and advertising activities; |
| ● | General economic conditions, including consumer access to disposable income and other conditions affecting purchasing power such as inflation and the interest rate environment; |
| ● | Labor and production costs; |
| ● | Cost of complying with regulation, including the “deeming regulation”, as well as the unpredictable nature of the regulatory regimes; |
| ● | Increasing and unpredictable regulation and/or marketing order decisions impacting Creative Distribution Solutions products; |
| ● | Counterfeit and other illegal products in our end-markets; |
| ● | Our ability to identify attractive acquisition opportunities; and |
| ● | Our ability to successfully integrate acquisitions. |
Critical Accounting Policies and Uses of Estimates
There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2023 Annual Report on Form 10-K.
Recent Accounting Pronouncements
See Item 1 of Part I, “Notes to Consolidated Financial Statements - Note 1 - Business and Basis of Presentation - Recent Accounting Pronouncements.”
Results of Operations
Comparison of the Three Months Ended June 30, 2024, to the Three Months Ended June 30, 2023
The table and discussion set forth below displays our consolidated results of operations (in thousands):
| | Three Months Ended June 30, | |
| | 2024 | | | 2023 | | | % Change | |
Consolidated Results of Operations Data: | | | | | | | | | |
Net sales | | | | | | | | | |
Zig-Zag products | | $ | 50,482 | | | $ | 46,722 | | | | 8.0 | % |
Stoker’s products | | | 42,743 | | | | 36,056 | | | | 18.5 | % |
Total Zig-Zag and Stoker’s products | | | 93,225 | | | | 82,778 | | | | 12.6 | % |
Creative Distribution Solutions | | | 15,287 | | | | 22,817 | | | | -33.0 | % |
Total net sales | | | 108,512 | | | | 105,595 | | | | 2.8 | % |
Cost of sales | | | 54,671 | | | | 53,117 | | | | 2.9 | % |
Gross profit | | | | | | | | | | | | |
Zig-Zag products | | | 26,872 | | | | 26,422 | | | | 1.7 | % |
Stoker’s products | | | 23,524 | | | | 19,968 | | | | 17.8 | % |
Total Zig-Zag and Stoker’s products | | | 50,396 | | | | 46,390 | | | | 8.6 | % |
Creative Distribution Solutions | | | 3,445 | | | | 6,088 | | | | -43.4 | % |
Total gross profit | | | 53,841 | | | | 52,478 | | | | 2.6 | % |
| | | | | | | | | | | | |
Selling, general, and administrative expenses | | | 32,753 | | | | 31,933 | | | | 2.6 | % |
Other operating income | | | (1,674 | ) | | | – | | | NM | |
Operating income (loss) | | | | | | | | | | | | |
Zig-Zag products | | | 18,260 | | | | 17,000 | | | | 7.4 | % |
Stoker’s products | | | 17,862 | | | | 15,110 | | | | 18.2 | % |
Creative Distributions Solutions | | | (108 | ) | | | 460 | | | | -123.5 | % |
Total segment operating income | | | 36,014 | | | | 32,570 | | | | 10.6 | % |
Corporate unallocated | | | (13,252 | ) | | | (12,025 | ) | | | 10.2 | % |
Total operating income | | | 22,762 | | | | 20,545 | | | | 10.8 | % |
Interest expense, net | | | 2,991 | | | | 4,019 | | | | -25.6 | % |
Investment loss | | | 2,439 | | | | 4,080 | | | | -40.2 | % |
Gain on extinguishment of debt | | | – | | | | (600 | ) | | NM | |
Income before income taxes | | | 17,332 | | | | 13,046 | | | | 32.9 | % |
Income tax expense | | | 4,415 | | | | 3,338 | | | | 32.3 | % |
Consolidated net income | | | 12,917 | | | | 9,708 | | | | 33.1 | % |
Net loss attributable to non-controlling interest | | | (87 | ) | | | (217 | ) | | | -59.9 | % |
Net income attributable to Turning Point Brands, Inc. | | $ | 13,004 | | | $ | 9,925 | | | | 31.0 | % |
Net Sales: For the three months ended June 30, 2024, consolidated net sales increased $2.9 million, or 2.8% compared to the prior year period, driven by an increase in the Zig-Zag and Stoker’s segments partially offset by a decline in the Creative Distribution Solutions segment.
For the three months ended June 30, 2024, net sales in the Zig-Zag Products segment increased $3.8 million, or 8.0% compared to the prior year period. The increase in net sales was driven primarily by an increase of $3.8 million of growth in our cigar products and $1.2 million of growth in our Canadian products business, partially offset by a decline of $1.6 million in our Clipper business against trade load in the prior year.
For the three months ended June 30, 2024, net sales in the Stoker’s Products segment increased $6.7 million, or 18.5% compared to the prior year period. For the three months ended June 30, 2024, volume increased 5.3% as compared with the prior year period contributing $1.9 million to the increase, and price/product mix increased 13.2% which contributed $4.8 million to the increase. The increase in net sales was driven by $3.5 million of growth of Stoker’s® MST and $3.4 million of growth in our modern oral product FRE, partially offset by a $0.1 million decline in net sales of loose-leaf chewing tobacco.
For the three months ended June 30, 2024, net sales in the Creative Distribution Solutions segment decreased $7.5 million, or 33.0% compared to the prior year period. The decrease in net sales was primarily the result of lower volumes in the liquid nicotine distribution business, contributing $7.5 million to the decrease, and our strategic decision to eliminate certain unprofitable brands and to focus on a narrower set of products.
Gross Profit: For the three months ended June 30, 2024, consolidated gross profit increased $1.4 million, or 2.6% compared to the prior year period. Gross profit as a percentage of net sales decreased slightly to 49.6% for the three months ended June 30, 2024, compared to 49.7% for the three months ended June 30, 2023.
For the three months ended June 30, 2024, gross profit in the Zig-Zag Products segment increased $0.5 million, or 1.7% compared to the prior year period. Gross profit as a percentage of net sales decreased to 53.2% of net sales for the three months ended June 30, 2024, from 56.6% of net sales for the three months ended June 30, 2023, driven primarily by growth during the quarter in our Canadian products business described above, and higher net sales of cigar products, which generate a lower margin than other products in the segment.
For the three months ended June 30, 2024, gross profit in the Stoker’s Products segment increased $3.6 million, or 17.8% compared to the prior year period. Gross profit as a percentage of net sales decreased to 55.0% of net sales for the three months ended June 30, 2024, from 55.4% of net sales for the three months ended June 30, 2023, primarily driven by Stoker’s MST net sales growth at higher margins, and higher net sales of FRE, though at lower margins than other products in the segment.
For the three months ended June 30, 2024, gross profit in the Creative Distribution Solutions segment decreased $2.6 million, or 43.4% compared to the prior year period. Gross profit as a percentage of net sales decreased to 22.5% of net sales for the three months ended June 30, 2024, from 26.7% of net sales for the three months ended June 30, 2023, primarily as a result of sales channel mix as business-to-business net sales which generates lower margins than business-to-consumer sales increased to 70% of net sales for the three months ended June 30, 2024 from 65% of net sales for the three months ended June 30, 2023.
Selling, General, and Administrative Expenses: For the three months ended June 30, 2024, selling, general, and administrative expenses increased $0.8 million, or 2.6% compared to the prior year period. Selling, general and administrative expenses in the three months ended June 30, 2024, included $1.9 million of stock options, restricted stock and incentives expense, $1.0 million of expense related to PMTA, $0.5 million of expense related to the implementation of the new ERP and CRM systems, $0.3 million of expense related to corporate restructuring and $0.1 million of transaction costs. Selling, general and administrative expenses in the three months ended June 30, 2023, included $2.1 million of stock options, restricted stock and incentives expense, $0.7 million of expense related to PMTA, $0.1 million of transaction costs and $0.1 million of expense related to the implementation of the new ERP and CRM systems.
Other Operating Income: For the three months ended June 30, 2024, other operating income increased $1.7 million compared to the prior year period due to a federal excise tax refund of $1.7 million received in the second quarter of 2024.
Operating Income (Loss): For the three months ended June 30, 2024, consolidated operating income increased $2.2 million, or 10.8% compared to the prior year period. Operating income as a percentage of net sales increased to 21.0% of net sales for the three months ended June 30, 2024 from 19.5% of net sales for the three months ended June 30, 2023, primarily driven by increased gross profit in the Stoker’s and Zig-Zag products segments, partially offset by decreased gross profit in the Creative Distribution Solutions segment.
For the three months ended June 30, 2024, operating income in the Zig-Zag Products segment increased $1.3 million, or 7.4% compared to the prior year period. Operating income as a percentage of net sales increased to 16.8% of net sales for the three months ended June 30, 2024 from 16.1% of net sales for the three months ended June 30, 2023, primarily driven by increased gross profit in our Canadian products business, U.S. Wraps and cigar products, combined with lower operational costs.
For the three months ended June 30, 2024, operating income in the Stoker’s Products segment increased $2.8 million, or 18.2% compared to the prior year period. Operating income as a percentage of net sales increased to 16.5% of net sales for the three months ended June 30, 2024 from 14.3% of net sales for the three months ended June 30, 2023, primarily driven by Stoker’s MST net sales growth at higher margins, and higher net sales of FRE which represented a higher percentage of the segment’s sales compared to the prior year period and has lower margins than other products in the segment.
For the three months ended June 30, 2024, operating income in the Creative Distribution Solutions segment decreased $0.6 million, or 123.5% compared to the prior year period. Operating income as a percentage of net sales decreased to (0.1)% of net sales for the three months ended June 30, 2024, from 0.4% of net sales for the three months ended June 30, 2023, primarily driven by a decline in gross profit that was not matched with cost savings. The decline was expected in light of our decision to focus on more profitable products.
Included in consolidated operating income are costs of the Company which are not assigned to one of the three reportable segments and includes: (i) corporate overhead expense, including executive management, finance, legal and information technology salaries, and professional services, such as audit, external legal costs and information technology services, as well as (ii) costs related to the FDA premarket tobacco product application. For the three months ended June 30, 2024, unallocated costs were $13.3 million compared to $12.0 million in the prior year period, an increase of $1.2 million or 10.2%.
Interest Expense, net: For the three months ended June 30, 2024, interest expense, net decreased $1.0 million compared to the prior year period as a result of the repurchase of $30.1 million of Convertible Senior Notes in the second and third quarters of 2023, and increased interest income on cash deposits due to rising interest rates.
Investment Loss: For the three months ended June 30, 2024, we had an investment loss of $2.4 million compared to a $4.1 million loss for the three months ended June 30, 2023. The change is primarily the result of an impairment charge recognized on our investments in Bomani for $1.8 million and Old Pal for $0.8 million in the second quarter of 2024, compared to an impairment charge recognized on our investment in Docklight for $3.8 million in the second quarter of 2023.
Gain on Extinguishment of Debt: There was no gain or loss on extinguishment of debt for the three months ended June 30, 2024 compared to a $0.6 million gain on extinguishment of debt for the three months ended June 30, 2023 as a result of repurchasing $15.1 million of Convertible Senior Notes in the second quarter of 2023.
Income Tax Expense: Our income tax expense of $4.4 million was 25.5% of income before income taxes for the three months ended June 30, 2024. Our effective income tax rate was 25.6% for the three months ended June 30, 2023.
Net Income (Loss) Attributable to Non-Controlling Interest: Net loss attributable to non-controlling interest was $0.1 million for the three months ended June 30, 2024 compared to $0.2 million net loss for the three months ended June 30, 2023.
Net Income Attributable to Turning Point Brands, Inc.: Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the three months ended June 30, 2024 and 2023, was $13.0 million and $9.9 million, respectively.
Comparison of the Six Months Ended June 30, 2024, to the Six Months Ended June 30, 2023
The table and discussion set forth below displays our consolidated results of operations (in thousands):
| | Six Months Ended June 30, | |
| | 2024 | | | 2023 | | | % Change | |
Consolidated Results of Operations Data: | | | | | | | | | |
Net sales | | | | | | | | | |
Zig-Zag products | | $ | 97,178 | | | $ | 88,609 | | | | 9.7 | % |
Stoker’s products | | | 79,111 | | | | 69,718 | | | | 13.5 | % |
Total Zig-Zag and Stoker’s products | | | 176,289 | | | | 158,327 | | | | 11.3 | % |
Creative Distribution Solutions | | | 29,281 | | | | 48,224 | | | | -39.3 | % |
Total net sales | | | 205,570 | | | | 206,551 | | | | -0.5 | % |
Cost of sales | | | 99,817 | | | | 105,456 | | | | -5.3 | % |
Gross profit | | | | | | | | | | | | |
Zig-Zag products | | | 54,409 | | | | 48,812 | | | | 11.5 | % |
Stoker’s products | | | 44,339 | | | | 39,433 | | | | 12.4 | % |
Total Zig-Zag and Stoker’s products | | | 98,748 | | | | 88,245 | | | | 11.9 | % |
Creative Distribution Solutions | | | 7,005 | | | | 12,850 | | | | -45.5 | % |
Total gross profit | | | 105,753 | | | | 101,095 | | | | 4.6 | % |
| | | | | | | | | | | | |
Selling, general, and administrative expenses | | | 65,399 | | | | 62,708 | | | | 4.3 | % |
Other operating income | | | (1,674 | ) | | | – | | | NM | |
Operating income (loss) | | | | | | | | | | | | |
Zig-Zag products | | | 36,259 | | | | 30,641 | | | | 18.3 | % |
Stoker’s products | | | 33,258 | | | | 29,672 | | | | 12.1 | % |
Creative Distribution Solutions | | | (110 | ) | | | 721 | | | | -115.3 | % |
Total segment operating income | | | 69,407 | | | | 61,034 | | | | 13.7 | % |
Corporate unallocated | | | (27,379 | ) | | | (22,647 | ) | | | 20.9 | % |
Total operating income | | | 42,028 | | | | 38,387 | | | | 9.5 | % |
Interest expense, net | | | 6,470 | | | | 8,029 | | | | -19.4 | % |
Investment loss | | | 2,320 | | | | 8,879 | | | | -73.9 | % |
Gain on extinguishment of debt | | | – | | | | (1,377 | ) | | NM | |
Income before income taxes | | | 33,238 | | | | 22,856 | | | | 45.4 | % |
Income tax expense | | | 8,142 | | | | 5,806 | | | | 40.2 | % |
Consolidated net income | | | 25,096 | | | | 17,050 | | | | 47.2 | % |
Net income (loss) attributable to non-controlling interest | | | 82 | | | | (472 | ) | | | -117.4 | % |
Net income attributable to Turning Point Brands, Inc. | | $ | 25,014 | | | $ | 17,522 | | | | 42.8 | % |
Net Sales: For the six months ended June 30, 2024, consolidated net sales decreased $1.0 million, or 0.5% compared to the prior year period, driven by a decline in the Creative Distribution Solutions segment partially offset by an increase in the Stoker’s and Zig-Zag Products segments.
For the six months ended June 30, 2024, net sales in the Zig-Zag Products segment increased $8.6 million, or 9.7% compared to the prior year period. The increase in net sales was driven primarily by $4.9 million of growth in Wraps and U.S. Papers, $3.8 million of growth in cigars, $1.4 million of growth in our Canadian products business and $1.8 million of growth in the alternative channel, partially offset by declines of $3.2 million in our Clipper business against trade load in the prior year.
For the six months ended June 30, 2024, net sales in the Stoker’s Products segment increased $9.4 million, or 13.5% compared to the prior year period. For the six months ended June 30, 2024, volume increased 2.8% as compared with the prior year period contributing $2.0 million to the increase, and price/product mix increased 10.6% which contributed $7.4 million to the increase. The increase in net sales was driven primarily by $5.1 million of growth of modern oral product FRE and $5.0 million of growth of Stoker’s MST, partially offset by a $0.6 million decline in loose-leaf chewing tobacco.
For the six months ended June 30, 2024, net sales in the Creative Distribution Solutions segment decreased $18.9 million, or 39.3% compared to the prior year period. The decrease in net sales was primarily the result of reduced volumes in the liquid nicotine distribution business contributing $18.9 million to the decrease, and our strategic decision to eliminate certain unprofitable brands and to focus on a narrower set of products.
Gross Profit: For the six months ended June 30, 2024, consolidated gross profit increased $4.7 million, or 4.6% compared to the prior year period. Gross profit as a percentage of net sales increased to 51.4% for the six months ended June 30, 2024, compared to 48.9% for the six months ended June 30, 2023, primarily driven by increased margins as the Creative Distribution Solutions segment became a smaller part of the overall company.
For the six months ended June 30, 2024, gross profit in the Zig-Zag Products segment increased $5.6 million, or 11.5% compared to the prior year period. Gross profit as a percentage of net sales increased to 56.0% of net sales for the six months ended June 30, 2024, from 55.1% of net sales for the six months ended June 30, 2023 as a result of product mix. Net sales increased in U.S. Papers and Wraps products which generate a higher gross margin than Clipper products in which net sales declined.
For the six months ended June 30, 2024, gross profit in the Stoker’s Products segment increased $4.9 million, or 12.4% compared to the prior year period. Gross profit as a percentage of net sales decreased to 56.0% of net sales for the six months ended June 30, 2024, from 56.6% of net sales for the six months ended June 30, 2023, as a result of product mix as the growth in our modern oral product FRE, which generates lower margins as compared with other products in the Stoker’s Products segment, outpaced the growth of MST.
For the six months ended June 30, 2024, gross profit in the Creative Distribution Solutions segment decreased $5.8 million, or 45.5% compared to the prior year period. Gross profit as a percentage of net sales decreased to 23.9% of net sales for the six months ended June 30, 2024, from 26.6% of net sales for the six months ended June 30, 2023, primarily as a result of sales channel mix as business-to-business net sales, which generate lower margins than business-to-consumer sales, increased to 83% of net sales for the six months ended June 30, 2024 from 79% of net sales for the six months ended June 30, 2023.
Selling, General, and Administrative Expenses: For the six months ended June 30, 2024, selling, general, and administrative expenses increased $2.7 million, or 4.3%. Selling, general and administrative expenses in the six months ended June 30, 2024, included $4.0 million of stock options, restricted stock and incentives expense, $1.9 million of expense related to PMTA, $1.5 million of expense related to corporate restructuring, $0.7 million of expense related to the implementation of the new ERP and CRM systems and $0.1 million related to transaction costs. Selling, general and administrative expenses in the six months ended June 30, 2023, included $2.8 million of stock options, restricted stock and incentives expense, $0.8 million of expense related to PMTA, $0.3 million of expense related to the implementation of the new ERP and CRM systems and $0.1 million related to transaction costs.
Other Operating Income: For the six months ended June 30, 2024, other operating income increased $1.7 million compared to the prior year period due to a federal excise tax refund of $1.7 million received in the first half of 2024.
Operating Income (Loss): For the six months ended June 30, 2024, consolidated operating income increased $3.6 million, or 9.5% compared to the prior year period. Operating income as a percentage of net sales increased to 20.4% of net sales for the six months ended June 30, 2024 from 18.6% of net sales for the six months ended June 30, 2023, primarily driven by increased gross profit in the Stoker's and Zig-Zag Products segments partially offset by decreased gross profit in the Creative Distribution Solutions segment.
For the six months ended June 30, 2024, operating income in the Zig-Zag Products segment increased $5.6 million, or 18.3% compared to the prior year period. Operating income as a percentage of net sales increased to 17.6% of net sales for the six months ended June 30, 2024 from 14.8% of net sales for the six months ended June 30, 2023, primarily driven by increased gross profit in our Canadian products business, U.S. Wraps and papers products.
For the six months ended June 30, 2024, operating income in the Stoker’s Products segment increased $3.6 million, or 12.1% compared to the prior year period. Operating income as a percentage of net sales increased to 16.2% of net sales for the six months ended June 30, 2024 from 14.4% of net sales for the six months ended June 30, 2023, primarily driven by Stoker’s MST net sales growth at higher margins and higher net sales of FRE.
For the six months ended June 30, 2024, operating income in the Creative Distribution Solutions segment decreased $0.8 million, or 115.3% compared to the prior year period. Operating income as a percentage of net sales decreased to (0.1)% of net sales for the six months ended June 30, 2024, from 0.3% of net sales for the six months ended June 30, 2023, primarily driven by a decline in gross profit that was not matched with cost savings.
Included in consolidated operating income are costs of the Company which are not assigned to one of the three reportable segments and includes: (i) corporate overhead expense, including executive management, finance, legal and information technology salaries, and professional services, such as audit, external legal costs and information technology services, as well as (ii) costs related to the FDA premarket tobacco product application. For the six months ended June 30, 2024, unallocated costs were $27.4 million compared to $22.6 million in the prior year period, an increase of $4.7 million or 20.9%.
Interest Expense, net: For the six months ended June 30, 2024, interest expense, net decreased $1.6 million compared to the prior year period as a result of the repurchases of $44.0 million of Convertible Senior Notes in 2023, and increased interest income on cash as a result of rising interest rates.
Investment Loss: For the six months ended June 30, 2024, investment loss decreased to $2.3 million compared to $8.9 million for the six months ended June 30, 2023. The change is primarily the result of an impairment charge recognized on our investments in Bomani for $1.8 million and Old Pal for $0.8 million in the second quarter of 2024, compared to an impairment charge of $8.7 million in the first half of 2023 related to our investment in Docklight.
Gain on Extinguishment of Debt: There was no gain or loss on extinguishment of debt for the six months ended June 30, 2024 compared to a gain on extinguishment of debt of $1.4 million for the six months ended June 30, 2023 as a result of repurchasing $29.0 million of Convertible Senior Notes in the first half of 2023.
Income Tax Expense: Our income tax expense of $8.1 million was 24.5% of income before income taxes for the six months ended June 30, 2024. Our effective income tax rate was 25.4% for the six months ended June 30, 2023.
Net Income (Loss) Attributable to Non-Controlling Interest: Net income attributable to non-controlling interest was $0.1 million for the six months ended June 30, 2024 compared to a $0.5 million loss for the six months ended June 30, 2023.
Net Income Attributable to Turning Point Brands, Inc.: Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the six months ended June 30, 2024 and 2023, was $25.0 million and $17.5 million, respectively.
EBITDA and Adjusted EBITDA
To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our debt instruments contain covenants which use Adjusted EBITDA calculations.
We define “EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider the ordinary course in our evaluation of ongoing operating performance noted in the reconciliation below. Among other items that we adjust Adjusted EBITDA for is FDA PMTA expense. The Company believes it is appropriate to adjust for this spend as the costs are incurred in connection with what we view as a non-traditional regulatory process that requires applications be submitted for covered products that are already on the market. As a result, Company’s management believes it is most appropriate to assess the performance of the Company’s business – the sale of our various products - without regard to these costs and believes that adjusting for these costs provides investors and the public markets with the most meaningful metrics to assess performance of the business.
Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.
(in thousands) | | Three Months Ended June 30, | | | Six Months Ended June 30, | |
| | 2024 | | | 2023 | | | 2024 | | | 2023 | |
Net income attributable to Turning Point Brands, Inc. | | $ | 13,004 | | | $ | 9,925 | | | $ | 25,014 | | | $ | 17,522 | |
Add: | | | | | | | | | | | | | | | | |
Interest expense, net | | | 2,991 | | | | 4,019 | | | | 6,470 | | | | 8,029 | |
Gain on extinguishment of debt | | | – | | | | (600 | ) | | | – | | | | (1,377 | ) |
Income tax expense | | | 4,415 | | | | 3,338 | | | | 8,142 | | | | 5,806 | |
Depreciation expense | | | 891 | | | | 759 | | | | 1,658 | | | | 1,535 | |
Amortization expense | | | 931 | | | | 771 | | | | 1,817 | | | | 1,542 | |
EBITDA | | $ | 22,232 | | | $ | 18,212 | | | $ | 43,101 | | | $ | 33,057 | |
Components of Adjusted EBITDA | | | | | | | | | | | | | | | | |
Corporate and CDS restructuring (a) | | | 283 | | | | – | | | | 1,544 | | | | – | |
ERP/CRM (b) | | | 489 | | | | 138 | | | | 627 | | | | 276 | |
Stock options, restricted stock, and incentives expense (c) | | | 1,889 | | | | 2,093 | | | | 3,951 | | | | 2,836 | |
Transactional expenses and strategic initiatives (d) | | | 97 | | | | 82 | | | | 127 | | | | 86 | |
FDA PMTA (e) | | | 997 | | | | 662 | | | | 1,838 | | | | 820 | |
Non-cash asset impairment (f) | | | 2,722 | | | | 4,092 | | | | 2,722 | | | | 8,989 | |
FET Refund (g) | | | (1,674 | ) | | | – | | | | (1,674 | ) | | | – | |
Adjusted EBITDA | | $ | 27,035 | | | $ | 25,279 | | | $ | 52,236 | | | $ | 46,064 | |
(a) | Represents costs associated with corporate and CDS restructuring, including severance. |
(b) | Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses. |
(c) | Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units. |
(d) | Represents the fees incurred for transaction expenses. |
(e) | Represents costs associated with applications related to FDA premarket tobacco product application (“PMTA”). The PMTA regime requires the Company to submit an application to the FDA to receive marketing authorization to continue to sell certain of its product lines with continued sales permitted during the pendency of the applications. The application is a onetime resource-intensive process for each covered product line; however, due to the nature of the implementation process for those product lines already in the market, applications can take multiple years to complete rather than the typical one-time submission. The Company currently has only two product lines currently subject to the PMTA process, having utilized other regulatory pathway options available for our other product lines. The Company does not expect to submit additional PMTA applications for any new product lines after the submission for the remaining two are complete. |
(f) | Represents impairment of investment assets. |
(g) | Represents a federal excise tax refund included in other operating income. |
Liquidity and Capital Resources
As of June 30, 2024, we have $142.2 million of cash on hand and have $58.8 million of availability under the 2023 ABL Facility. Our principal uses for cash are working capital, debt service, and capital expenditures.
Our Convertible Senior Notes, with an outstanding balance of $118.5 million as of June 30, 2024, matured on July 15, 2024 and are reported in current liabilities on the Company's Consolidated Balance Sheet. The Convertible Senior Notes were retired on July 15, 2024 with cash, leaving us with pro forma cash of $23.7 million and no borrowings outstanding under our ABL as of June 30, 2024.
Our adjusted working capital, which we define as current assets less cash and current liabilities, decreased $62.6 million compared to the prior year end. The decrease in working capital is primarily a result of a $60.2 million increase in current liabilities due to the July 15, 2024 maturity of our Convertible Senior Notes which were retired on that date. With our strong cash balance, free cash flow generation and borrowing availability under the 2023 ABL Facility, we expect to have ample liquidity to satisfy our operating cash requirements for the foreseeable future.
| | As of | |
(in thousands) | | June 30, 2024 | | | December 31, 2023 | |
| | | | | | |
Current assets | | $ | 147,578 | | | $ | 149,730 | |
Current liabilities | | | 160,817 | | | | 100,336 | |
Adjusted working capital | | $ | (13,239 | ) | | $ | 49,394 | |
Our cash flows from operations as reflected in the Consolidated Statements of Cash Flows are summarized as follows:
(in thousands) | | Six Months Ended June 30, | |
Cash provided by (used in): | | 2024 | | | 2023 | |
Operating activities | | $ | 36,077 | | | $ | 27,533 | |
Investing activities | | $ | (7,972 | ) | | $ | (2,990 | ) |
Financing activities | | $ | (6,747 | ) | | $ | (30,431 | ) |
Cash Flows from Operating Activities
For the six months ended June 30, 2024, net cash provided by operating activities was $36.1 million, an increase of $8.5 million compared to the prior year period, primarily due to an increase in net income, net of non-cash items of $4.5 million, and an increase in the change in other assets of $4.3 million. The primary drivers of non-cash items were a $6.3 million decrease in loss on investments compared to the prior year period, partially offset by a $1.1 million increase in stock compensation expense and a $1.4 million decrease in gains on extinguishment of debt compared to the prior year period. The increase in other assets was primarily driven by cash paid for capitalized software in 2023 that did not repeat in 2024.
Cash Flows from Investing Activities
For the six months ended June 30, 2024, net cash used in investing activities was $8.0 million, an increase of $5.0 million compared to the prior year period, primarily due to the net purchase of $4.6 million in investments by our captive insurance subsidiary.
Cash Flows from Financing Activities
For the six months ended June 30, 2024, net cash used in financing activities was $6.7 million, a decrease of $23.7 million compared to the prior year period, primarily due to the repurchase of $27.4 million of Convertible Senior Notes that occurred during the period in 2023 that did not repeat in 2024, partially offset by an increase in repurchases of common stock of $3.1 million during the period in 2024.
Dividends and Share Repurchase
A dividend of $0.07 per common share was paid on July 5, 2024, to shareholders of record at the close of business on June 14, 2024.
On February 25, 2020, our Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. The program is subject to the ongoing discretion of the Board of Directors. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million and by an additional $24.6 million on February 24, 2022. In the three and six months ended June 30, 2024, the Company repurchased $1.0 million and $3.1 million of common stock, respectively, with $24.1 million remaining available for share repurchases under the program as of June 30, 2024.
Long-Term Debt
Notes payable and long-term debt consisted of the following at June 30, 2024 and December 31, 2023, in order of preference:
| | June 30, 2024 | | | December 31, 2023 | |
Senior Secured Notes | | $ | 250,000 | | | $ | 250,000 | |
Convertible Senior Notes | | | 118,541 | | | | 118,541 | |
Gross notes payable and long-term debt | | | 368,541 | | | | 368,541 | |
Less deferred finance charges | | | (2,111 | ) | | | (3,183 | ) |
Less current maturities | | | (118,470 | ) | | | (58,294 | ) |
Notes payable and long-term debt | | $ | 247,960 | | | $ | 307,064 | |
Senior Secured Notes
On February 11, 2021, we closed a private offering (the “Offering”) of $250 million aggregate principal amount of our 5.625% senior secured notes due 2026 (the “Senior Secured Notes”). The Senior Secured Notes bear interest at a rate of 5.625% and will mature on February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.We used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.
Obligations under the Senior Secured Notes are guaranteed by the Company’s existing and future wholly-owned domestic subsidiaries (the “Guarantors”) that guarantee any credit facility (as defined in the indenture governing the Senior Secured Notes or the “Senior Secured Notes Indenture”) or capital markets debt securities of the Company or Guarantors in excess of $15.0 million. The Senior Secured Notes and the related guarantees are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.
The Company may redeem the Senior Secured Notes, in whole or in part, at any time, at the redemption prices (expressed as a percentage of the principal amount to be redeemed) set forth below, plus accrued and unpaid interest, if any, on the Senior Secured Notes to be redeemed to (but not including) the applicable redemption date if redeemed during the period indicated below:
On or after February 15, 2024 | 101.406% |
On or after February 15, 2025 and thereafter | 100.000% |
If we experience a change of control (as defined in the Senior Secured Notes Indenture), we must offer to repurchase the Senior Secured Notes at a repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.
The Senior Secured Notes Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Senior Secured Notes Indenture. For instance, the Company is generally permitted to make restricted payments, including the payment of dividends to shareholders, provided that, at the time of payment, or as a result of payment, the Company is not in default on its debt covenants; however, there are earnings and market capitalization requirements that if not met could limit the aggregate amount of quarterly dividends payable during a fiscal year. The Senior Secured Notes Indenture provides for customary events of default. We were in compliance with all covenants as of June 30, 2024.
We incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $6.4 million which are amortized to interest expense using the straight-line method over the expected life of the Senior Secured Notes.
2021 Revolving Credit Facility
In connection with the Offering, we also entered into a $25.0 million senior secured revolving credit facility (the “2021 Revolving Credit Facility”) with the lenders party thereto and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). This facility was terminated in November 2023 in connection with the entry by a subsidiary of the Company in a new asset-backed revolving credit facility. See “2023 ABL Facility” below. We incurred debt issuance costs attributable to the issuance of the 2021 Revolving Credit Facility of $0.5 million, with the remaining $0.2 million written off to gain on debt extinguishment upon termination of the facility in November 2023.
2023 ABL Facility
On November 7, 2023, TPB Specialty Finance, LLC, a wholly-owned subsidiary of the Company (the “ABL Borrower”), entered into a new $75.0 million asset-backed revolving credit facility (the “2023 ABL Facility”), with the several lenders thereunder, and Barclays Bank Plc, as administrative agent (the “Administrative Agent”) and as collateral agent (the “Collateral Agent”) and First-Citizens Bank & Trust Company as additional collateral agent (the “Additional Collateral Agent”). Under the 2023 ABL Facility, the ABL Borrower may draw up to $75.0 million under Revolving Credit Loans and Last In Last Out (“LILO”) Loans. The 2023 ABL Facility includes a $40.0 million accordion feature. In connection with the 2023 ABL Facility, Turning Point Brands contributed certain existing inventory to the ABL Borrower. The 2023 ABL Facility is secured on a first priority basis (subject to customary exceptions) by all assets of the ABL Borrower.
The 2023 ABL Facility contains customary borrowing conditions including a borrowing base equal to the sum of (a) the lesser of (1) 85% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) 85% of the cost of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (2) 85% of the net orderly liquidation value (“NOLV”) percentage of the lower of (1)(A) or (1)(B); plus (b) 85% of the face value of all eligible accounts of the ABL Borrower minus (c) the amount of all eligible reserves. The 2023 ABL Facility also includes a LILO borrowing base equal to the sum of (a) the lesser of: (1) 10% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) the cost of the sum of eligible inventory, plus eligible in-transit inventory and (2) 10% of the NOLV percentage of the lower of (1)(A) or (1)(B); plus (b) 10% of the face amount of eligible account; minus (c) the amount of all eligible reserves.
Amounts borrowed under the 2023 ABL Facility are subject to an interest rate margin per annum equal to (a) from and after the closing date until the last day of the first full fiscal quarter ended after the closing date, (i) 1.25% per annum, in the case base rate loans, and (ii) 2.25% per annum, in the case of revolving credit loans that are SOFR Loans, (b)(i) 2.25% per annum, in the case of LILO loans that are base rate loans, and (ii) 3.25% per annum, in the case of LILO loans that are SOFR loans, (c) on the first day of each fiscal quarter, the applicable interest rate margins will be determined from the pricing grid below based upon the historical excess availability for the most recent fiscal quarter ended immediately prior to the relevant date, as calculated by the Administrative Agent.
Level | | Historical Excess Availability | Applicable Margin for SOFR Loans | Applicable Margin for Base Rate Loans |
I | | Greater than or equal to 66.66% | 1.75% | 0.75% |
II | | Less than 66.66%, but greater than or equal to 33.33% | 2.00% | 1.00% |
III | | Less than 33.33% | 2.25% | 1.25% |
The 2023 ABL Facility also requires the Company and its restricted subsidiaries to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 as of the end of any four consecutive fiscal quarters if excess availability is less than the greater of (a) 12.5% of the line cap and (b) $9.4 million, at any time and continuing until excess availability is equal to or exceeds the greater of (i) 12.5% of the line and (ii) $9.4 million for thirty (30) consecutive calendar days with the $9.4 million level automatically increased in proportion to the amount of any increase in the aggregate revolving credit commitments thereunder in connection with any incremental facility.
The 2023 ABL Facility will mature on the earlier of (x) November 7, 2027 and (y) the date that is 91 days prior to the maturity date of any material debt of the ABL Borrower or the Company or any of its restricted subsidiaries (subject to customary extensions agreed by the lenders thereunder); provided that clause (y) will not apply to the extent that on any applicable date of determination (on any date prior to the date set forth in clause (y)), (A) the sum of (x) cash that is held in escrow for the repayment of such material debt pursuant to arrangements satisfactory to the Administrative Agent, (y) cash that is held in accounts with the Administrative Agent and/or the Additional Collateral Agent, plus (z) excess availability, is sufficient to repay such material debt and (B) the ABL Borrower has excess availability of at least $15.0 million after giving effect to such repayment of material debt, including any borrowings under the commitments in connection therewith.
The Company has not drawn any borrowings under the 2023 ABL Facility but has letters of credit of approximately $2.6 million outstanding under the facility and has an available balance of $58.8 million based on the borrowing base as of June 30, 2024.
The Company incurred debt issuance costs attributable to the 2023 ABL Facility of $2.6 million which are amortized to interest expense using the straight-line method over the expected life of the 2023 ABL Facility.
Convertible Senior Notes
In July 2019, the Company closed an offering of $172.5 million in aggregate principal amount of its 2.50% Convertible Senior Notes due July 15, 2024 (the “Convertible Senior Notes”). The Convertible Senior Notes bear interest at a rate of 2.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The Convertible Senior Notes are senior unsecured obligations of the Company.
In 2023, a wholly owned subsidiary of the Company repurchased $44.0 million in aggregate principal amount of the Convertible Senior Notes on the open market resulting in a $1.9 million gain on extinguishment of debt. The repurchased notes were retired on July 1, 2024, with $118.5 million aggregate principal remaining outstanding and held by third parties as of June 30, 2024.
The Convertible Senior Notes held by third parties were convertible into shares of TPB common stock, par value $0.01 per share (“Common Stock”), under certain circumstances prior to maturity. The conditions required to allow the holders to convert their Convertible Senior Notes were not met as of June 30, 2024. The Convertible Senior Notes matured on July 15, 2024 and were retired with cash. As of June 30, 2024, $118.5 million aggregate principal is recorded in current liabilities on the Company’s Consolidated Balance Sheet.
The Company incurred debt issuance costs attributable to the Convertible Senior Notes of $5.9 million which are amortized to interest expense using the straight-line method over the expected life of the Convertible Senior Notes.
Off-balance Sheet Arrangements
During the six months ended June 30, 2024, we executed various foreign exchange contracts for the purchase and sale of €1.5 million with maturity dates ranging from October to December 2024. At June 30, 2024, we had foreign currency contracts outstanding for the purchase of €6.1 million and sale of €6.1 million, with maturities ranging from July to December 2024. The fair value of the foreign currency contracts were based on quoted market prices and resulted in an asset of $0.0 million included in Other current assets and a liability of $0.1 million included in Accrued liabilities at June 30, 2024. During 2023, we executed various foreign exchange contracts for the purchase of €20.1 million and sale of €15.2 million. At December 31, 2023, we had foreign currency contracts outstanding for the purchase of €15.2 million and sale of €15.2 million. The fair value of the foreign currency contracts were based on quoted market prices and resulted in an asset of $0.3 million included in Other current assets and a liability of $0.1 million included in Accrued liabilities at December 31, 2023.
Inflation
Inflation in general, coupled with increases in gas prices have had a substantial negative effect on the purchasing power of consumers. While historically, we have been able to increase prices at a rate equal to or greater than that of inflation, doing so would be difficult in the current inflationary environment. However, we have implemented price increases in areas where doing so has been feasible. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our successful procurement regarding our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Foreign Currency Sensitivity
During the quarter ended June 30, 2024, there have been no material changes in our exposure to exchange rate fluctuation risk, as reported within our 2023 Annual Report on Form 10-K. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2023 Annual Report on Form 10-K filed with the SEC.
Credit Risk
There have been no material changes in our exposure to credit risk, as reported within our 2023 Annual Report on Form 10-K, during the six months ended June 30, 2024. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2023 Annual Report on Form 10-K filed with the SEC.
Interest Rate Sensitivity
In February 2021, we issued the Senior Secured Notes in an aggregate principal amount of $250 million. In July 2019, we issued Convertible Senior Notes in an aggregate principal amount of $172.5 million. We carry the Senior Secured Notes and Convertible Senior Notes at face value. Since the Senior Secured Notes and Convertible Senior Notes bear interest at a fixed rate, we have no financial statement risk associated with changes in interest rates. However, the fair value of the Convertible Senior Notes changes when the market price of our stock fluctuates, or interest rates change. The Convertible Senior Notes matured on July 15, 2024 and were retired with cash. Our remaining debt instrument is the 2023 ABL Facility, which has no borrowing outstanding.
Item 4. Controls and Procedures
We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934), as of June 30, 2024. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are not effective as of such date solely due to material weaknesses in internal controls over financial reporting that were disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
As previously described in Part II, Item 9A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, during our evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2023, we concluded that our internal control over financial reporting was not effective solely due to the existence of the following material weakness:
We did not design and maintain effective internal controls related to our information technology general controls (“ITGCs”) in the areas of user access and program change-management over certain information technology (“IT”) systems that support the Company’s financial reporting processes. Our business process controls (automated and manual) that are dependent on the affected ITGCs were also deemed ineffective because they could have been adversely impacted. We believe that these control deficiencies were a result of: IT control processes lacking sufficient documentation such that the successful operation of ITGCs was overly dependent upon knowledge and actions of certain individuals with IT expertise and inherent system limitations.
The material weakness did not result in any identified misstatements to our financial statements, and there were no changes to previously released financial results. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time, and management has concluded through testing that these controls are operating effectively.
Remediation Plan
While our remediation plan may evolve and expand, management has been implementing and continues to implement measures designed to ensure that control deficiencies contributing to the material weakness are remediated, such that these controls are designed, implemented, and operating effectively. The remediation actions include: (i) completion of the current implementation of a new ERP system in 2025; (ii) developing and maintaining documentation underlying ITGCs; (iii) implementing an IT management review and testing plan to monitor ITGCs with a specific focus on systems supporting our financial reporting processes; and (iv) enhanced quarterly reporting on the remediation measures to the Audit Committee of the Board of Directors.
We believe that these actions will ultimately remediate the material weakness. The material weakness will not be considered remediated, however, until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
For a description of our material pending legal proceedings, please see Contingencies in Note 14 to the Notes to the Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report.
See ‘Risk Factors—We are subject to significant product liability litigation’ within our 2023 Annual Report on Form 10-K for additional details.
In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our 2023 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2023 Annual Report on Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On February 25, 2020, the Company’s Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million bringing the authority at the time back to $50.0 million (including approximately $19.3 million available for repurchases under the Board of Directors’ previous authorization). On February 24, 2022, the Board of Directors increased the approved share repurchase program by $24.6 million bringing total authority at that time to $50.0 million. At June 30, 2024, the Company had $24.1 million of remaining capacity under the share repurchase program. This share repurchase program has no expiration date and is subject to the ongoing discretion of the Board of Directors. All repurchases to date under our stock repurchase programs have been made through open market transactions, but in the future, we may also purchase shares through privately negotiated transactions or 10b5-1 repurchase plans.
The following table includes information regarding purchases of our common stock made by us during the quarter ended June 30, 2024 in connection with the repurchase program described above.
| | | | | | | | Total Number of | | | Approximate Dollar | |
| | | | | | | | Shares Purchased | | | Value of Shares | |
| | Total Number | | | Average | | | as Part of Publicly | | | that May Yet Be | |
| | of Shares | | | Price Paid | | | Announced Plans | | | Purchased Under the | |
Period | | Purchased (1) | | | per Share | | | or Programs | | | Plans or Programs | |
April 1 to April 30 | | | 48,356 | | | $ | 26.54 | | | | 34,350 | | | $ | 24,146,985 | |
May 1 to May 31 | | | 9,101 | | | $ | 33.15 | | | | – | | | $ | 24,146,985 | |
June 1 to June 30 | | | – | | | $ | – | | | | – | | | $ | 24,146,985 | |
Total | | | 57,457 | | | | | | | | 34,350 | | | | | |
(1) | The total number of shares purchased includes shares withheld by the Company in an amount equal to the statutory withholding taxes for holders who vested in stock-based awards, which totaled 14,006 shares in April and 9,101 shares in May. Shares withheld by the Company to cover statutory withholdings taxes are repurchased pursuant to the applicable plan and not the authorization under the share repurchase program. |
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Not applicable.
Exhibit No. | Description |
| |
| Rule 13a-14(a)/15d-14(a) Certification of Graham Purdy.* |
| |
| Rule 13a-14(a)/15d-14(a) Certification of Andrew Flynn.* |
| |
| Rule 13a-14(a)/15d-14(a) Certification of Brian Wigginton.* |
| |
| Section 1350 Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.* |
| |
101 | XBRL (eXtensible Business Reporting Language). The following materials from Turning Point Brands, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, filed on August 1, 2024, formatted in Inline XBRL (iXBRL): (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of comprehensive income, (iv) consolidated statements of cash flows, and (v) the notes to consolidated financial statements.* |
| |
104 | Cover Page Interactive Data File (formatted in iXBRL and included in Exhibit 101).* |
* | Filed or furnished herewith |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| TURNING POINT BRANDS, INC. |
| | |
| | By: /s/ Graham Purdy |
| | Name: | Graham Purdy |
| | | Title: President and Chief Executive Officer |
| | |
| | By: /s/ Andrew Flynn |
| | Name: | Andrew Flynn |
| | | Title: Chief Financial Officer |
| | |
| | By: /s/ Brian Wigginton |
| | Name: | Brian Wigginton |
| | | Title: Chief Accounting Officer |
| | |
Date: August 1, 2024 | | |
49